SYNSAM Synsam AB (publ)
Synsam AB (publ), together with its subsidiaries, operates in the optical retail and eye health sector in the Nordic Region. The company offers lenses, frames, sunglasses, sports spectacles, contact lenses, eye care accessories, and hearing aids. It also provides eye health services, hearing tests, lifestyle subscriptions, contact lens subscriptions, personal style advice services, and eye examination services, including physical and online examination services. The company offers its products and services through directly owned and franchised stores, as well as through e-commerce warehouses in Sweden, Denmark, Norway, Iceland, Faroe Islands, and Finland under the Synsam, Profil Optik, Fellepini, Oscar Eide, EyeQ, Jämtö, and Index brands. Synsam AB (publ) was founded in 1968 and is headquartered in Stockholm, Sweden.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Synsam (STO: SYNSAM)
›
Synsam (STO: SYNSAM) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 5,600 employees.
The shares were at 60.50 SEK on 19 November 2026, down 0.6% over 52 weeks. Its 52-week range is 49.80 SEK to 72.10 SEK: the price is 16.1% below the high and 21.5% above the low.
At a market capitalisation of 8.46B SEK, it trades at 16.1 times trailing earnings and 15.1 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 67% for SYNSAM. It pays a dividend yielding 2.92% (it pays out 48% of its earnings), against a median of 0.93% among the dividend payers in that peer group.
Synsam reports return on equity of 18.6%, an operating margin of 12.3% and revenue up 9.9% year over year.
Its debt exceeds its cash by 3.11B SEK, a debt-to-equity ratio of 1.46. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 77.00 SEK is 27.3% above the current price. The next earnings report is expected on 18 February 2027.